Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

India’s production, Russia’s export of Sputnik vaccine at risk due to Ukraine crisis

India's production and exports of Russia's Sputnik COVID-19 vaccines are expected to slow further following U.S. sanctions on Russia's sovereign wealth fund that promotes...

Technopolis Moscow will start production twenty vital drugs

The production of 20 vital and essential medicines is planned to be launched in SEZ Technopolis Moscow by the end of 2022. This was...

Pfizer’s vaccine for bacterial infection fails to meet trial goal

Pfizer Inc said on Tuesday its vaccine to prevent infections from a bacteria that mainly spreads through hospitals and doctors' offices and can even...

Biocon to acquire Viatris’ biosimilars assets for up to $3.335 bln

Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced that it has entered into a definitive agreement with its partner Viatris Inc. Accordingly, Biocon...

FDA refuses to approve Gilead HIV medication on glass vial concerns

Gilead Sciences, Inc. announced the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the New Drug Application (NDA)...

La Jolla Institute for Immunology and Charles River Laboratories to collaborate on COVID-19 research

Scientists at LJI and Charles River Laboratories, are launching a new project to uncover exactly how different cells in the human immune system respond...
spot_img

Expert Articles

spot_img